Evidence map›Paper›PMID 28770403›Full record

Trial reportTranslational stroke research2018

Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial.

Lisa J Woodhouse, Polly Scutt, Shaheen Hamdy, David G Smithard, David L Cohen, Christine Roffe, Daniel Bereczki, Eivind Berge, Christopher F Bladin, Valeria Caso and 13 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational stroke research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 15 countries.

Lisa J WoodhouseStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.
Polly ScuttStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.
Shaheen HamdyCentre for Gastrointestinal Sciences, University of Manchester, Salford, UK.
David G SmithardElderly Medicine, Princess Royal University Hospital, Orpington, UK.
David L CohenElderly Medicine, Northwick Park Hospital, Harrow, UK.
Christine RoffeInstitute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK.
Daniel BereczkiNeurology, Semmelweis University, Balassu, Budapest, Hungary.
Eivind BergeOslo University Hospital, Oslo, Norway.
Christopher F BladinThe Florey Institute of Neuroscience & Mental Health Melbourne Brain Centre-Austin Campus, Heidelberg, Australia.
Valeria CasoStroke Unit, Ospedale Santa Maria della Misericordia di Perugia, Perugia, Italy.
Hanne K ChristensenNeurology, Bispebjerg Hospital & University of Copenhagen, Copenhagen, Denmark.
Rónán CollinsStroke Service, Tallaght Hospital, Tallaght Dublin, Ireland.
Anna CzlonkowskaNeurology 2, Institute of Psychiatry and Neurology, Warsaw, Poland.
Asita de SilvaClinical Trials Unit, University of Kelaniya, Ragama, Sri Lanka.
Anwar EtribiNeurology, Ainshams University, Cairo, Egypt.
Ann-Charlotte LaskaClinical Sciences, Karolinska Institute, Stockholm, Sweden.
George NtaiosMedicine, University of Thessaly, Larissa, Greece.
Serefnur OzturkNeurology, Selcuk University, Konya, Turkey.
Stephen J PhillipsDivision of Neurology, Halifax Infirmary, Halifax, Canada.
Kameshwar PrasadNeurology, All India Institute of Medical Sciences, New Delhi, India.
Szabolcs SzatmariNeurology, Clinical County Emergency Hospital, Targu Mures, Romania.
Nikola SpriggStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.
Philip M BathStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK. philip.bath@nottingham.ac.uk.
Nottingham City Hospital · GBAin Shams University · EGAll India Institute of Medical Sciences · INBispebjerg Hospital · DKDartmouth General Hospital · CAFlorey Institute of Neuroscience and Mental Health · AUInstitute of Psychiatry and Neurology · PLKarolinska Institutet · SEKeele University · GBNorthwick Park Hospital · GBNottingham University Hospitals NHS Trust · GBOslo University Hospital · NOOspedale Santa Maria · ITPrincess Royal University Hospital · GBSelçuk University · TRSemmelweis University · HUTallaght University Hospital · IEUniversity of Kelaniya · LKUniversity of Nottingham · GBUniversity of Salford · GB

Funding

Bupa Foundation N/RMedical Research Council G0501797
6 · The paper itself

Abstract

Post-stroke dysphagia is common, associated with poor outcome and often requires non-oral feeding/fluids. The relationship between route of feeding and outcome, as well as treatment with glyceryl trinitrate (GTN), was studied prospectively. The Efficacy of Nitric Oxide in Stroke (ENOS) trial assessed transdermal GTN (5 mg versus none for 7 days) in 4011 patients with acute stroke and high blood pressure. Feeding route (oral = normal or soft diet; non-oral = nasogastric tube, percutaneous endoscopic gastrostomy tube, parenteral fluids, no fluids) was assessed at baseline and day 7. The primary outcome was the modified Rankin Scale (mRS) measured at day 90. At baseline, 1331 (33.2%) patients had non-oral feeding, were older, had more severe stroke and more were female, than 2680 (66.8%) patients with oral feeding. By day 7, 756 patients had improved from non-oral to oral feeding, and 119 had deteriorated. Non-oral feeding at baseline was associated with more impairment at day 7 (Scandinavian Stroke Scale 29.0 versus 43.7; 2p < 0.001), and worse mRS (4.0 versus 2.7; 2p < 0.001) and death (23.6 versus 6.8%; 2p = 0.014) at day 90. Although GTN did not modify route of feeding overall, randomisation ≤6 h of stroke was associated with a move to more oral feeding at day 7 (odds ratio = 0.61, 95% confidence intervals 0.38, 0.98; 2p = 0.040). As a proxy for dysphagia, non-oral feeding is present in 33% of patients with acute stroke and associated with more impairment, dependency and death. GTN moved feeding route towards oral intake if given very early after stroke. Clinical Trial Registration Clinical Trial Registration-URL: http://www.controlled-trials.com . Unique identifier: ISRCTN99414122.

Indexed as

Deglutition DisordersNitric OxideAgedAged, 80 and overFeeding MethodsFemaleHumansMaleMiddle AgedNitroglycerinRespiratory Tract InfectionsStrokeTime FactorsTreatment OutcomeVasodilator AgentsNitric OxideNitroglycerinVasodilator AgentsDysphagiaGlyceryl trinitrateOutcomeRandomised controlled trialStroke

Identifiers

PMID28770403
PMCPMC5849635
OpenAlexW2741704041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.